Clinical Trials Logo

Graft Versus Host Disease in Eye clinical trials

View clinical trials related to Graft Versus Host Disease in Eye.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05294666 Completed - Clinical trials for Graft Versus Host Disease in Eye

Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

Start date: April 1, 2020
Phase: Phase 4
Study type: Interventional

It is planned to explore the efficacy and safety of local 0.05% cyclosporine eye drops in the treatment of chronic graft-versus-host eye disease. Through the comparative study with 0.1% tacrolimus eye drops, to clarify the short-term and long-term efficacy of 0.05% CSA in these patients, and to explore the benefits of long-term maintenance of local cyclosporine to patients.